IOmx Therapeutics
iOmx Therapeutics focuses on the development of first-in-class cancer therapeutics.
IOmx Therapeutics has raised €105M across 2 funding rounds from 7 investors, most recently a Series B round in Oct 2021. Based in Munich, Germany; founded 2016; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€105M
€105,000,000
Funding rounds
2
Investors
7
distinct backers
Active since
2016-09
latest 2021-10
Funding by year
EUR raised per yearIOmx Therapeutics — funding by year — interactive chart.
Data table
| IOmx Therapeutics — funding by year | |
|---|---|
| 2016 | €40M |
| 2021 | €65M |
Signals
High confidenceRaise-next likelihood10
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood11
base rate 11% (2+ rounds)
- ▲ €100M+ raised
- ▲ 10y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-10-05 | Series B | €65M | Athos Service,M Ventures,MIG Capital,Sofinnova Partners,Wellington Partners | View deal → |
| 2016-09-01 | Series A | €40M | Merck Ventures,MPM Capital,Sofinnova Partners,Wellington Partners | View deal → |
Investors
7Related news
Similar companies
same sector or country- Delivery Hero€7.1BGermany · E-commerce
- Enpal€4.6BGermany · Cleantech
- Auxmoney€3.5BGermany · Fintech
- Helsing€2.9BGermany · AI
- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
Global coverage: FundingData